Rodrigo Dientsmann

25PUBLICATIONS

256CO-AUTHORS

Molecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHumoural immunology and immunochemistry

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (25)

Sort by Publication Date:

|Jul 13, 2026

Application of a translational research platform to unveil efficacy signals and mechanisms of resistance of FGFR inhibitors in multiple FGFR-altered solid tumors.

|Apr 24, 2026

Maximizing the impact of real-world evidence on cancer treatment: what do we need to achieve it?

|Apr 03, 2026

Clinical Response to Poly(ADP-ribose) Polymerase Inhibitor in Metastatic Breast Cancer With a Germline Reduced-Penetrance BRCA2 Pathogenic Variant: A Molecular Tumor Board Discussion.

Diocésio Alves Pinto de Andrade, Carlos Alberto Fruet Filho, Cristiane Alves Mendes

|Feb 24, 2026

Interrogating the immune landscape of microsatellite stable RAS-mutated colon cancer.

Rodrigo Dienstmann, Eduardo García-Galea, Alice O'Farrell

|Feb 04, 2026

Bevacizumab for Metastatic Colorectal Cancer with Chromosomal Instability: Cost-Effectiveness Analysis for a Novel Precision Treatment Approach in Germany, Ireland and Spain.

Jonathan Briody, Ian S Miller, James F O'Mahony

|Dec 16, 2025

Broad Utility of Ultrasensitive Analysis of ctDNA Dynamics across Solid Tumors Treated with Immunotherapy.

Elena Garralda, Charles Abbott, Alma Calahorro

Pageof 5

Frequent Collaborators

Paolo Nuciforo

Elena Garralda

Josep Tabernero

Rodrigo Toledo

Cristina Viaplana

Carlos Gil Ferreira

Raquel Perez-Lopez

Marta Ligero

Matheus Costa E Silva

3 joint publications

Roberta Fasani

Frequent Collaborators

Paolo Nuciforo

Elena Garralda

Josep Tabernero

Rodrigo Toledo